Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Beyond the Abstract - Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices

January 18th, 2010

Beyond the Abstract - Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices

Abstract:
Methods to augment the biological action of radiation therapy in prostate and other tumors without additional toxicity to surrounding normal tissues would be useful for improving the therapeutic ratio.

In order to achieve high spatial accuracy, modern radiation therapy practice routinely utilizes implantation of fiducials (external beam therapy) or radioactive source spacers (brachytherapy) into the tumor. These implantable devices are an essential technical component of radiation delivery during Image Guided Radiation Therapy (IGRT), but are inert and provide no direct therapeutic function.

The next step will be to test the method (termed BIS-IGRT, Biological In-Situ enhanced IGRT) in animal models. A series of drug-loaded devices is under development for this purpose, in collaboration with nanotechnology and nanomedicine experts at Northeastern University, in order to look at the tumor-sensitizing properties of the implants.

Source:
urotoday.com

Bookmark:

Related News Press

News and information

Synthesis of superconducting picene crystals December 12th, 2013

Iranian Scientists Discover New Electrical Device for Rapid Diagnosis of Cancer December 12th, 2013

3-D Analysis of Thermo-elastic Behavior of Composite Plate Graded with Carbon Nanotubes December 12th, 2013

Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Scheduled for Wednesday, December 18, 2013 December 12th, 2013

Nanomedicine

Low-power tunneling transistor for high-performance devices at low voltage December 12th, 2013

Chicago Awareness Organization First Not-for-Profit to Sponsor Dog Training to Detect Ovarian Cancer Odorants December 12th, 2013

Iranian Scientists Discover New Electrical Device for Rapid Diagnosis of Cancer December 12th, 2013

Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Scheduled for Wednesday, December 18, 2013 December 12th, 2013

Announcements

Synthesis of superconducting picene crystals December 12th, 2013

Iranian Scientists Discover New Electrical Device for Rapid Diagnosis of Cancer December 12th, 2013

3-D Analysis of Thermo-elastic Behavior of Composite Plate Graded with Carbon Nanotubes December 12th, 2013

Arrowhead to Report Fiscal 2013 Fourth Quarter and Year-End Financial Results - Conference Call Scheduled for Wednesday, December 18, 2013 December 12th, 2013

Nanobiotechnology

The gene sequencing that everyone can afford in future December 6th, 2013

DNA helicity and elasticity explained on the nanoscale: Korean researchers propose simple model to explain DNA helicity and elasticity on a nanometer scale December 5th, 2013

NanCogenics Co-Founder Invited to Present Talk at the Nanotek 2013 International Conference and Expo in Las Vegas, NV December 3rd, 2013

Making a gem of a tiny crystal: Slowly cooled DNA transforms disordered nanoparticles into orderly crystal November 27th, 2013